VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 206 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,160,671 | +152.6% | 123,871 | +561.3% | 0.14% | +141.4% |
| Q2 2023 | $459,496 | -59.7% | 18,732 | -61.8% | 0.06% | -55.0% |
| Q1 2023 | $1,140,928 | -19.8% | 49,030 | -12.7% | 0.13% | -20.4% |
| Q4 2022 | $1,422,093 | -20.4% | 56,187 | -39.4% | 0.16% | -16.9% |
| Q3 2022 | $1,787,000 | -39.7% | 92,712 | -20.4% | 0.20% | -33.2% |
| Q2 2022 | $2,965,000 | +99.1% | 116,415 | +101.1% | 0.29% | +82.5% |
| Q1 2022 | $1,489,000 | – | 57,895 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $40,100,000 | 21.56% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,216,644 | $571,412,000 | 2.71% |
| Nan Fung Group Holdings Ltd | 210,563 | $5,416,000 | 2.57% |
| Taikang Asset Management (Hong Kong) Co Ltd | 533,332 | $13,717,000 | 2.34% |
| Crawford Lake Capital Management, LLC | 168,200 | $4,326,000 | 1.80% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 126,900 | $3,264,000 | 1.75% |
| Zebra Capital Management LLC | 22,227 | $572,000 | 1.31% |
| Alaska Permanent Fund Corp | 2,300,000 | $59,156,000 | 0.98% |
| CLARK ESTATES INC/NY | 180,000 | $4,630,000 | 0.73% |
| Temasek Holdings (Private) Ltd | 5,602,553 | $144,097,663 | 0.61% |